Nebius Just Raised $5 Billion in Convertible Notes Against a $1.4 Billion Revenue Base. Are We In a Bubble?

Nebius priced a $5.0B upsized convertible senior notes deal (from $4.5B), with conversion prices of $313.46 (2030, ~0.50% coupon) and $324.65 (2034, 4.50% coupon), and optional add-on proceeds up to $750M. While the coupons look low, accretion and redemption step-ups imply a much higher effective cost (near $258M/year, ~19% of trailing revenue), and potential dilution is cited at ~6% if shares rise ~40% or more. The company plans to spend heavily—Q2 capex was ~$5.7B vs $582.3M revenue—to build its AI cloud/data centers, and shares fell about 10% on the offering news, reflecting concern about funding needs and valuation.

Analysis

This is less a financing event than a signal that NBIS is still effectively selling future equity to buy present capacity. The near-term winner is the GPU supply chain, especially NVDA, because a balance sheet like this keeps incremental demand for accelerators intact even if customer economics are still unproven; the loser is the common equity, where dilution plus accretion means the true financing burden is much higher than the headline coupon suggests. In other words, the market is not just funding growth — it is underwriting a rising claim stack on a still-thin revenue base.

The key risk is timing mismatch: capex and depreciation hit now, while monetization depends on power delivery, utilization, and customer prepayments over the next 2-6 quarters. If AI cloud pricing softens or GPU refresh cycles shorten, NBIS can be forced back into the market before the current buildout compounds into free cash flow, which would compress the multiple further. The first falsifier is evidence that capex intensity is falling materially or that contracted ARR is converting into cash faster than depreciation and financing expense.

Contrarianly, the market may be over-discounting the funding need if the prepayment pipeline is real and if NBIS can lock in customers before capacity is live; that would make the current dilution look like a bridge rather than a leak. But absent a visible step-down in quarterly capex or a clear path to positive levered FCF, the equity remains a financing vehicle wrapped around an operating business. Over 1-3 months the stock is vulnerable to every reminder of that, while 6-18 months the real question is whether it becomes a scaled infrastructure asset or just a capital recycler.

Key Decisions for Investors

• Short NBIS on financing-overhang rallies over the next 1-3 months; thesis is that the equity market will keep discounting future dilution until capex intensity falls or FCF inflects. Risk/reward improves if the stock reclaims the post-deal selloff range without a better cash conversion story.
• Pair trade: long NVDA / short NBIS for 1-3 months. This isolates the beneficiary of continued AI infrastructure spend versus the issuer that must repeatedly raise capital to fund it; the spread should work unless NBIS shows an unexpectedly fast path to self-funding.
• Use a bearish options structure on NBIS into any strength: buy put spreads 2-4 months out rather than outright puts, since the implied move is likely elevated and the main catalyst is a financing/dilution reassessment rather than a one-day event.
• Watch for a falsifier: if NBIS reports a material reduction in quarterly capex or a sharp step-up in cash receipts/prepayments within the next earnings cycle, cover short exposure. That would indicate the market is underestimating working-capital support and asset utilization.